136 related articles for article (PubMed ID: 38644522)
1. Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study.
Krajewski PK; Matusiak Ł; Ständer S; Thaçi D; Szepietowski JC; Zirpel H
Int J Dermatol; 2024 Jun; 63(6):799-805. PubMed ID: 38644522
[TBL] [Abstract][Full Text] [Related]
2. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa and the risk of myocardial infarction, cerebrovascular accident, and peripheral vascular disease: a population-based study.
Kridin K; Valido K; Cohen JM; Cohen AD
Arch Dermatol Res; 2023 Apr; 315(3):429-435. PubMed ID: 35871185
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of cardiovascular comorbidities in hidradenitis suppurativa: A nationwide, population-based, cohort study in Taiwan.
Hung CT; Chiang CP; Chung CH; Tsao CH; Chien WC; Wang WM
J Dermatol; 2019 Oct; 46(10):867-873. PubMed ID: 31389066
[TBL] [Abstract][Full Text] [Related]
5. Association of metabolic syndrome and hidradenitis suppurativa.
Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa as a potential risk factor of periodontitis: a multi-center, propensity-score-matched cohort study.
Gau SY; Guo YC; Lu HY; Lin CY; Lee CY; Tsai RY; Chang HC; Wu MC; Li CP
Int J Med Sci; 2024; 21(5):874-881. PubMed ID: 38617008
[No Abstract] [Full Text] [Related]
7. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients.
Shalom G; Freud T; Harman-Boehm I; Polishchuk I; Cohen AD
Br J Dermatol; 2015 Aug; 173(2):464-70. PubMed ID: 25760289
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa.
Reddy S; Strunk A; Jemec GBE; Garg A
JAMA Dermatol; 2020 Jan; 156(1):65-71. PubMed ID: 31721983
[TBL] [Abstract][Full Text] [Related]
9. Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa.
Egeberg A; Gislason GH; Hansen PR
JAMA Dermatol; 2016 Apr; 152(4):429-34. PubMed ID: 26885728
[TBL] [Abstract][Full Text] [Related]
10. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
[TBL] [Abstract][Full Text] [Related]
11. Risk of Chronic Kidney Disease in Hospitalized Patients with Hidradenitis Suppurativa.
Almuhanna N; Tobe SW; Alhusayen R
Dermatology; 2023; 239(6):912-918. PubMed ID: 37487485
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.
Tzellos T; Zouboulis CC; Gulliver W; Cohen AD; Wolkenstein P; Jemec GB
Br J Dermatol; 2015 Nov; 173(5):1142-55. PubMed ID: 26153913
[TBL] [Abstract][Full Text] [Related]
13. Risk of Keratitis and Keratopathy in Hidradenitis Suppurativa Patients: A Global Federated Health Network Analysis.
Gau SY; Liu PY; Chen SN; Chiu TM; Tsai RY; Chang HC; Li CP
In Vivo; 2024; 38(3):1375-1383. PubMed ID: 38688616
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for the management of comorbidity in hidradenitis suppurativa.
Dauden E; Lazaro P; Aguilar MD; Blasco AJ; Suarez C; Marin I; Queiro R; Bassas-Vila J; Martorell A; García-Campayo J
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):129-144. PubMed ID: 28796920
[TBL] [Abstract][Full Text] [Related]
15. Association between hidradenitis suppurativa and atopic diseases: a multi-center, propensity-score-matched cohort study.
Chang HC; Lin CY; Guo YC; Lu HY; Lee CY; Wu MC; Gau SY
Int J Med Sci; 2024; 21(2):299-305. PubMed ID: 38169580
[No Abstract] [Full Text] [Related]
16. Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS).
González-López MA; Hernández JL; Lacalle M; Mata C; López-Escobar M; López-Mejías R; Portilla V; Fuentevilla P; Corrales A; González-Vela MC; González-Gay MA; Blanco R
J Am Acad Dermatol; 2016 Aug; 75(2):329-35. PubMed ID: 27287248
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case-control study.
Dumont LM; Landman C; Sokol H; Beaugerie L; Cosnes J; Seksik P; Guégan S;
Aliment Pharmacol Ther; 2020 Jul; 52(2):303-310. PubMed ID: 32525586
[TBL] [Abstract][Full Text] [Related]
18. Risk of osteoarthritis in patients with hidradenitis suppurativa: a global federated health network analysis.
Chang HC; Wu CL; Chiu TM; Liao WC; Gau SY
Front Immunol; 2023; 14():1285560. PubMed ID: 38173729
[TBL] [Abstract][Full Text] [Related]
19. Disease Trajectories for Hidradenitis Suppurativa in the Danish Population.
Kjærsgaard Andersen R; Jørgensen IF; Reguant R; Jemec GBE; Brunak S
JAMA Dermatol; 2020 Jul; 156(7):780-786. PubMed ID: 32432647
[TBL] [Abstract][Full Text] [Related]
20. Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa-A Monocentric Study in Germany.
Abu Rached N; Gambichler T; Ocker L; Dietrich JW; Quast DR; Sieger C; Seifert C; Scheel C; Bechara FG
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
